Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2645 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 48.0 | 51 | ||||
| N2645 | 2 | IL-17 | 46.0 | 59 | |||||||
| RA2708 | Tofacitinib | 0.3 | uM | 2 | IL-17 | 53.0 | 31 | ||||
| RA2708 | 2 | IL-17 | 42.0 | 33 | |||||||
| 0 | IL-17 | 51.0 | 35 | ||||||||
| 0 | IL-17 | 49.0 | 51 | ||||||||
| 0 | IL-17 | 50.0 | 55 | ||||||||
| 0 | IL-17 | 41.5 | 42 | ||||||||
| 0 | IL-17 | 37.0 | 50 | ||||||||
| 0 | IL-17 | 42.0 | 41 | ||||||||
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-17 | 34.0 | 59 | ||||
| RA1869 | IKK16 | 2.0 | uM | 3 | IL-17 | 31.0 | 64 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-17 | 35.0 | 75 | ||||
| N2759 | IKK16 | 2.0 | uM | 3 | IL-17 | 34.0 | 75 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-17 | 37.5 | 56 | ||||
| RA1931 | IKK16 | 2.0 | uM | 3 | IL-17 | 35.0 | 59 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-17 | 36.0 | 81 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | IL-17 | 39.0 | 69 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 3 | IL-17 | 34.0 | 81 | ||||
| RA1869 | 3 | IL-17 | 39.0 | 66 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 3 | IL-17 | 36.5 | 78 | ||||
| N2759 | 3 | IL-17 | 39.0 | 67 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 3 | IL-17 | 37.0 | 55 | ||||
| RA1931 | 3 | IL-17 | 34.5 | 52 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | IL-17 | 36.0 | 63 |